Dr Greg Roger was selected by the Federal Government to spearhead Medical Device commercialization in Australia. His broad industry, regulatory, engineering, and medical experience made him the stand out candidate for the role. He has more than 30 years experience in the field of medicine, bio-medical engineering, product development, and commercialisation. Having developed, patented, and commercialised medical devices, Dr Roger is familiar with the key issues of this industry for individuals through to larger corporations.
Vestech Medical Pty Limited
Founder and Managing Director: 1992 (as Cryptych Pty Ltd) – Present
Dr Roger founded and is currently Managing Director of Vestech, a company developing and licensing intellectual property in medical devices. He successfully led the start-up of the business and is now working with a team of bio-engineers to provide specialised biomedical engineering solutions and consultancy services for businesses and individuals.
New South Wales Hospitals
Various Medical Practitioner Roles: 1984 – Present
Dr Roger is currently employed and privately self employed as a medical practitioner. He has been an assistant in orthopaedic and spinal surgery, Acting Director of Casualty for accident and emergency victims and the Medical Director for the SLSA Rescue Helicopter Service.
Advanced Surgical Design & Manufacture Limited
Founder and Director: 1994 – 2012
Dr Roger successfully established Advanced Surgical Design & Manufacture Limited (ASDM). During his tenure in the role, Dr Roger oversaw the design, manufacture, and export of a number of orthopaedic and vascular surgery devices across the globe as well as ASDM’s listing on the ASX.
- Entrepreneur of the Year Award, Engineers Australia Sydney Division (2006).
- Hero of Innovation Award, Warren Centre, University of Sydney (2005).
- Clunies Ross Award, Academy of Technological Sciences and Engineering (2004).
- More than 20 US Patents granted.
- Assisted in the patenting process with dozens of collaborators.
- Significant experience in licensing and assignment deal making.
- On 1 August 2018